Renal response, N=28 (26%) | No response, N=80 (74%) | P value | |
Baseline UPCR, g/g Mean±SD | 5.6±1.9 | 6.9±2.6 | 0.02 |
Baseline albumin, g/L Mean±SD | 2.3±0.3 | 2.2±0.5 | 0.1 |
Change in UPCR at 24 weeks, g/g Mean±SD | −4.9±2.2 | −3.8±3.4 | 0.1 |
Change in albumin at 24 weeks, g/L Mean±SD | 1.1±0.5 | 1±0.5 | 0.5 |
Change in UPCR at 48 weeks, g/g Mean±SD | −5.5±2 | −4.3±3.9 | 0.1 |
Change in albumin at 48 weeks, g/L Mean±SD | 1.6±0.6 | 1.3±0.7 | 0.06 |
Duration of lupus nephritis, months Median (IQR range) | 6.3 (1.3–35) | 7.2 (1.6–43) | 0.5 |
Normalised C3, ≥90 mg/dL | 18 (64%) | 59 (74%) | 0.3 |
Treated with anti-CD20 | 18 (64%) | 48 (60%) | 0.6 |
Mixed with class 5 | 9 (32%) | 28 (35%) | 0.7 |
Change in systolic blood pressure, mm Hg Mean±SD | −24±21 | −13±21 | 0.02 |
Change in diastolic blood pressure, mm Hg Mean±SD | −13±18 | −6±16 | 0.04 |
Change in glomerular filtration rate, mL/min Mean±SD | 28±24 | 14±40 | 0.08 |
Change in creatinine, mg/dL Mean±SD | −0.15±0.2 | −0.09±0.5 | 0.5 |
UPCR, urine protein/creatinine ratio.